At the same time, patients with HRAS mutations were more frequent to develop skeletal bone abnormalities, including hypophosphatemic rickets, than patients with KRAS mutations (65 vs. 27%, OR = 5.0, 95%CI = 1.4– 18.1, p = 0.015). The gene discussed is HRAS; the disease is hypophosphatemic rickets.